(MoneyNewsWire.Net, January 11, 2018 ) According to the report Europe Ophthalmology Therapeutics Market, published by Market Data Forecast, the Global market is projected to reach USD 8.3 billion by 2022, at a CAGR of 6.9% from 2017 to 2022.
Ophthalmology is a medical branch that specializes and deals with anatomy, physiology and diseases related to eyeball and orbit. Ophthalmology Therapeutics include products that aid in treating the diseases related to eyes and complications that arise after conducting a medical procedure to eye.
Get a comprehensive overview of the Europe Ophthalmology Therapeutics Market: https://www.marketdataforecast.com/market-reports/europe-ophthalmology-therapeutics-market-1108/
Europe Ophthalmology Therapeutics Market: Drivers & Restraints
It is estimated that there are about 25 million people in European region with vision impairment. Major factors involved in driving the market are increasing cases and incidences of vision impairment, technological advancements in the field of medicine, growing geriatric population in the European region, increasing disposable income.
However, strict regulatory framework and poor reimbursement policies are the key challenges that are to be addressed by the market.
Get accurate market forecast and analysis on the Europe Ophthalmology Therapeutics Market. Request a sample to stay up-to-date on the main trends affecting this market: https://www.marketdataforecast.com/market-reports/europe-ophthalmology-therapeutics-market-1108/request-sample
Europe Ophthalmology Therapeutics Market: Segmentation
• Dry Eye Syndrome
• Diabetic Retinopathy
• Retinal Vein Occlusion
• Age-Related Macular Degeneration
• Macular Edema
• Allergic Conjunctivitis
By End Users
• Eye Clinics
• Diagnostic Centres
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at https://www.marketdataforecast.com/market-reports/europe-ophthalmology-therapeutics-market-1108/customize-report
Europe Ophthalmology Therapeutics Market: Overview
Based on Disease Identification, Retinal Disorders have accounted for the largest share in the market due to its high prevalence and incidence rates. The dry eye syndrome is expected to grow the fastest due to growing incidence of this condition, and prevalence of its risk factor diabetes mellitus.
Regionally, U.K. holds the major share in the market owing to increasing expenditure on healthcare and increasing number of ophthalmologists. Germany is expected to grow the fastest owing to rapid technological advancements that help in treating the diseases effectively and growing disposable income.
Europe Ophthalmology Therapeutics Market: Key Players
Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast